🔓 In their latest publication in the FEBS Journal, Kito et al. uncover a new player in how our bodies process Vitamin B6.
A new branch of mammalian vitamin B6 metabolism: AKR1C-mediated conversion of pyridoxal to pyridoxine and 4-pyridoxolactone➡️https://buff.ly/2vT1WQe
#vitaminB6 #salvage #AKR1C
A new branch of mammalian vitamin B6 metabolism: AKR1C-mediated conversion of pyridoxal to pyridoxine and 4-pyridoxolactone➡️https://buff.ly/2vT1WQe
#vitaminB6 #salvage #AKR1C
August 19, 2026 at 10:48 AM
🔓 In their latest publication in the FEBS Journal, Kito et al. uncover a new player in how our bodies process Vitamin B6.
A new branch of mammalian vitamin B6 metabolism: AKR1C-mediated conversion of pyridoxal to pyridoxine and 4-pyridoxolactone➡️https://buff.ly/2vT1WQe
#vitaminB6 #salvage #AKR1C
A new branch of mammalian vitamin B6 metabolism: AKR1C-mediated conversion of pyridoxal to pyridoxine and 4-pyridoxolactone➡️https://buff.ly/2vT1WQe
#vitaminB6 #salvage #AKR1C
RRIDs were included in this paper. RRIDs improve reproducibility in scientific research. #OpenResearch #STMpublishing #OpenScience
A new branch of mammalian vitamin B6 metabolism: AKR1C-mediated conversion of pyridoxal to pyridoxine and 4-pyridoxolactone
Read the full paper: A new branch of mammalian vitamin B6 metabolism: AKR1C-mediated conversion of pyridoxal to pyridoxine and 4-pyridoxolactone
doi.org
March 6, 2026 at 8:00 AM
RRIDs were included in this paper. RRIDs improve reproducibility in scientific research. #OpenResearch #STMpublishing #OpenScience
AKR1C mediates the acquired resistance to T-Dxd in a HER-2 positive gastric cancer line https://www.biorxiv.org/content/10.1101/2024.12.11.627923v1
December 12, 2024 at 4:57 PM
AKR1C mediates the acquired resistance to T-Dxd in a HER-2 positive gastric cancer line https://www.biorxiv.org/content/10.1101/2024.12.11.627923v1
AKR1C mediates the acquired resistance to T-Dxd in a HER-2 positive gastric cancer line https://www.biorxiv.org/content/10.1101/2024.12.11.627923v1
December 12, 2024 at 4:57 PM
AKR1C mediates the acquired resistance to T-Dxd in a HER-2 positive gastric cancer line https://www.biorxiv.org/content/10.1101/2024.12.11.627923v1